Pioglitazone did not reduce a composite endpoint of macrovascular complications and increased risk for heart failure in type 2 diabetes with macrovascular disease. [electronic resource]

By: Producer: 20060330Description: 34 p. digitalISSN:
  • 1056-8751
 In: ACP journal club vol. 144
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Comment; Journal Article

There are no comments on this title.

to post a comment.